Gene · 2091
Papers2,899
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,899
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RBP-RNA interactions in the control of autoimmunity and autoinflammation. | Cell Res | 2023 | 36599968 | PubTator, text mining | PubMed |
| PQBP5/NOL10 maintains and anchors the nucleolus under physiological and osmotic stress conditions. | Nat Commun | 2023 | 36599853 | PubTator, text mining | PubMed |
| Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth. | Neuro Oncol | 2023 | 36583853 | PubTator, text mining | PubMed |
| SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway. | Mol Carcinog | 2023 | 36562475 | PubTator, text mining | PubMed |
| LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis. | Thorac Cancer | 2023 | 36516959 | PubTator, text mining | PubMed |
Limb expression 1-like protein promotes epithelial-mesenchymal transition and epidermal growth factor receptor-tyrosine kinase inhibitor resistance via nucleolin-mediated ribosomal RNA synthesis in non-small cell lung cancer. | Cancer Sci | 2023 | 36478492 | PubTator, text mining | PubMed |
| Impact of Asp/Glu-ADP-ribosylation on protein-protein interaction and protein function. | Proteomics | 2023 | 36453556 | PubTator, text mining | PubMed |
| Long-noncoding RNAs as epigenetic regulators in neurodegenerative diseases. | Neural Regen Res | 2023 | 36453400 | PubTator, text mining | PubMed |
| Long Noncoding RNAs in the Prediction of Survival of Patients with Digestive Cancers. | Turk J Gastroenterol | 2023 | 36445051 | PubTator, text mining | PubMed |
| Systemic sclerosis. | Lancet | 2023 | 36442487 | PubTator, text mining | PubMed |
| Micro-Topographies Induce Epigenetic Reprogramming and Quiescence in Human Mesenchymal Stem Cells. | Adv Sci (Weinh) | 2023 | 36414384 | PubTator, text mining | PubMed |
| Autoreactive B cell responses targeting nuclear antigens in systemic sclerosis: Implications for disease pathogenesis. | Semin Arthritis Rheum | 2023 | 36403538 | PubTator, text mining | PubMed |
| SMA-linked SMN mutants prevent phase separation properties and SMN interactions with FMRP family members. | Life Sci Alliance | 2023 | 36375840 | PubTator, text mining | PubMed |
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group. | Mol Oncol | 2023 | 36370117 | PubTator, text mining | PubMed |
| Internal RNA 2'O-methylation in the HIV-1 genome counteracts ISG20 nuclease-mediated antiviral effect. | Nucleic Acids Res | 2023 | 36354007 | PubTator, text mining | PubMed |
| RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications. | Nucleic Acids Res | 2023 | 36300630 | PubTator, text mining | PubMed |
| Real-time imaging of RNA polymerase I activity in living human cells. | J Cell Biol | 2023 | 36282216 | PubTator, text mining | PubMed |
| RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | J Cell Biol | 2023 | 36282215 | PubTator, text mining | PubMed |
| A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia. | Cancer Discov | 2023 | 36259929 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2091/papers?page=20